申请人:Shionogi & Co., Ltd.
公开号:US04153629A1
公开(公告)日:1979-05-08
9,10-Dihydro-9,10-methanoanthracene N-oxide derivatives represented by the formula: ##STR1## wherein A represents a straight or branched C.sub.1 -C.sub.6 alkylene; R.sup.1 and R.sup.2 each represents C.sub.1 -C.sub.4 alkyl or phenyl-C.sub.1 -C.sub.4 alkyl, or ##STR2## represents the group ##STR3## and X represents methylene, hydroxymethylene, C.sub.1 -C.sub.4 ##STR4## or hydroxy-C.sub.1 -C.sub.4 ##STR5## and their pharmaceutically acceptable acid addition salts which are useful as anti-depressants, tranquilizers, or anti-epileptics.
该文献描述了以以下式子表示的9,10-二氢-9,10-甲基蒽N-氧化物衍生物:##STR1## 其中A代表直链或支链C.sub.1-C.sub.6烷基;R.sup.1和R.sup.2分别代表C.sub.1-C.sub.4烷基或苯基-C.sub.1-C.sub.4烷基,或者##STR2##代表基团##STR3##,X代表亚甲基、羟甲基、C.sub.1-C.sub.4 ##STR4##或羟基-C.sub.1-C.sub.4 ##STR5##,以及它们的药学上可接受的酸加盐,可用作抗抑郁剂、镇静剂或抗癫痫剂。